Black Rock Inc. Bluebird Bio, Inc. Put Options Transaction History
Black Rock Inc.
- $4.35 Trillion
- Q2 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding BLUE
# of Institutions
95Shares Held
49.8MCall Options Held
264KPut Options Held
428K-
Pictet Asset Management Sa Geneva 73, V84.67MShares$28.2 Million0.02% of portfolio
-
State Street Corp Boston, MA3.84MShares$23.2 Million0.0% of portfolio
-
Avidity Partners Management LP Dallas, TX1.63MShares$9.85 Million0.05% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1.61MShares$9.72 Million0.0% of portfolio
-
Lion Point Capital, LP New York, NY1.58MShares$9.53 Million2.2% of portfolio
About bluebird bio, Inc.
- Ticker BLUE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,121,800
- Market Cap $466M
- Description
- bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...